» Articles » PMID: 38443365

Neuronal MiR-9 Promotes HSV-1 Epigenetic Silencing and Latency by Repressing Oct-1 and Onecut Family Genes

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Mar 5
PMID 38443365
Authors
Affiliations
Soon will be listed here.
Abstract

Herpes simplex virus 1 (HSV-1) latent infection entails repression of viral lytic genes in neurons. By functional screening using luciferase-expressing HSV-1, we identify ten neuron-specific microRNAs potentially repressing HSV-1 neuronal replication. Transfection of miR-9, the most active candidate from the screen, decreases HSV-1 replication and gene expression in Neuro-2a cells. Ectopic expression of miR-9 from lentivirus or recombinant HSV-1 suppresses HSV-1 replication in male primary mouse neurons in culture and mouse trigeminal ganglia in vivo, and reactivation from latency in the primary neurons. Target prediction and validation identify transcription factors Oct-1, a known co-activator of HSV transcription, and all three Onecut family members as miR-9 targets. Knockdown of ONECUT2 decreases HSV-1 yields in Neuro-2a cells. Overexpression of each ONECUT protein increases HSV-1 replication in Neuro-2a cells, human induced pluripotent stem cell-derived neurons, and primary mouse neurons, and accelerates reactivation from latency in the mouse neurons. Mutagenesis, ChIP-seq, RNA-seq, ChIP-qPCR and ATAC-seq results suggest that ONECUT2 can nonspecifically bind to viral genes via its CUT domain, globally stimulate viral gene transcription, reduce viral heterochromatin and enhance the accessibility of viral chromatin. Thus, neuronal miR-9 promotes viral epigenetic silencing and latency by targeting multiple host transcription factors important for lytic gene activation.

Citing Articles

Global MicroRNA Profiling of HSV-1 Infected Cornea Identifies miR-329 as a Novel Regulator of Virus Infection.

Sharma P, Naqvi R, Borase H, Kapoor D, Valverde A, Capistrano K Invest Ophthalmol Vis Sci. 2025; 66(2):61.

PMID: 39992671 PMC: 11878248. DOI: 10.1167/iovs.66.2.61.


The opportunities and challenges of epigenetic approaches to manage herpes simplex infections.

Saddoris S, Schang L Expert Rev Anti Infect Ther. 2024; 22(12):1123-1142.

PMID: 39466139 PMC: 11634640. DOI: 10.1080/14787210.2024.2420329.


A review of HSV pathogenesis, vaccine development, and advanced applications.

Bai L, Xu J, Zeng L, Zhang L, Zhou F Mol Biomed. 2024; 5(1):35.

PMID: 39207577 PMC: 11362470. DOI: 10.1186/s43556-024-00199-7.


Models of Herpes Simplex Virus Latency.

Canova P, Charron A, Leib D Viruses. 2024; 16(5).

PMID: 38793628 PMC: 11125678. DOI: 10.3390/v16050747.

References
1.
Chambers S, Qi Y, Mica Y, Lee G, Zhang X, Niu L . Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol. 2012; 30(7):715-20. PMC: 3516136. DOI: 10.1038/nbt.2249. View

2.
Lee J, Raja P, Knipe D . Herpesviral ICP0 Protein Promotes Two Waves of Heterochromatin Removal on an Early Viral Promoter during Lytic Infection. mBio. 2016; 7(1):e02007-15. PMC: 4725016. DOI: 10.1128/mBio.02007-15. View

3.
Phelan D, Barrozo E, Bloom D . HSV1 latent transcription and non-coding RNA: A critical retrospective. J Neuroimmunol. 2017; 308:65-101. DOI: 10.1016/j.jneuroim.2017.03.002. View

4.
Arbuckle J, Vogel J, Efstathiou S, Kristie T . Deletion of the Transcriptional Coactivator HCF-1 Impairs the Removal of Repressive Heterochromatin from Latent HSV Genomes and Suppresses the Initiation of Viral Reactivation. mBio. 2023; 14(1):e0354222. PMC: 9973298. DOI: 10.1128/mbio.03542-22. View

5.
Rodriguez M, Dybas J, Hughes J, Weitzman M, Boutell C . The HSV-1 ubiquitin ligase ICP0: Modifying the cellular proteome to promote infection. Virus Res. 2020; 285:198015. PMC: 7303953. DOI: 10.1016/j.virusres.2020.198015. View